Novastar Ventures leads Series B investment into mPharma’s operations in Ghana for USD 9.73 million

Lead party: Novastar Ventures Limited (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: mPharma Data, Inc. (private company) · Sector: Healthcare, Medical Supplies · Countries of operation: Zambia, Ghana, Malawi, Nigeria, Gabon, Uganda, Zimbabwe, Kenya, Ethiopia, Rwanda Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture…


Lead party: Novastar Ventures Limited (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: mPharma Data, Inc. (private company) · Sector: Healthcare, Medical Supplies · Countries of operation: Zambia, Ghana, Malawi, Nigeria, Gabon, Uganda, Zimbabwe, Kenya, Ethiopia, Rwanda

Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Round: Series B · Deal amount: US$9.7m · Fund: 4DX Ventures Fund I

Lead investor/buyer: Novastar Ventures Limited · Investors/buyers: Novastar Ventures Limited, Kli Capital LLP, Daniel Vasella, 4DX Ventures Management LLC, Peregrine Ventures, Jim Breyer, Social Capital, Cem Garih, Unbound Ventures

Legal advisers: not identified in the source record.

Source: announced 16 January 2019. Original announcement: ventureburn.com.